| Oct 30, 2025 |
Nov 3, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
47.5
|
-19,889,683
|
-100.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
LAPORTE KATHLEEN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Hayden Michael R
|
Director |
Neutral |
47.5
|
-246,420
|
-100.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Martins Ryan
|
CFO |
Neutral |
47.5
|
-339,295
|
-100.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Altschuler Steven
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
PALEKAR ROHAN
|
CEO |
Neutral |
47.5
|
-809,273
|
-100.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
McWherter Charles
|
Director |
Neutral |
47.5
|
-25,000
|
-100.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Atkinson Edward Morrow III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Zoth Lota S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Le-Nguyen Quoc
|
Officer |
Neutral |
47.5
|
-315,378
|
-100.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
DiRocco Derek
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Sarena Francis Willard
|
COO |
Neutral |
47.5
|
-75,310
|
-100.00%
|
✗
|
- |
| Oct 30, 2025 |
Oct 30, 2025 |
Mansbach Harry H
|
Chief Medical Officer |
Neutral |
47.5
|
-302,656
|
-100.00%
|
✗
|
- |
| Oct 22, 2025 |
Oct 23, 2025 |
Martins Ryan
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 1, 2025 |
Aug 5, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
42.5
|
-8,202
|
-2.53%
|
✗
|
$75.1K |
| Aug 1, 2025 |
Aug 5, 2025 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
42.5
|
-7,680
|
-2.47%
|
✗
|
$70.3K |
| Aug 1, 2025 |
Aug 5, 2025 |
Martins Ryan
|
CFO |
Sell |
42.5
|
-7,680
|
-2.94%
|
✗
|
$70.3K |
| Aug 1, 2025 |
Aug 5, 2025 |
Sarena Francis Willard
|
COO |
Sell |
42.5
|
-6,185
|
-7.69%
|
✗
|
$58.2K |
| Aug 1, 2025 |
Aug 5, 2025 |
PALEKAR ROHAN
|
CEO |
Sell |
40.0
|
-55,836
|
-6.46%
|
✗
|
$511.5K |
| Jul 15, 2025 |
Jul 17, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
37.5
|
-10,461
|
-3.13%
|
✓
|
$115.3K |
| Jun 12, 2025 |
Jun 13, 2025 |
Martins Ryan
|
CFO |
Sell |
42.5
|
-8,498
|
-3.15%
|
✗
|
$81.8K |
| Jun 12, 2025 |
Jun 13, 2025 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
42.5
|
-8,498
|
-2.67%
|
✗
|
$81.8K |
| Jun 12, 2025 |
Jun 13, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
42.5
|
-9,032
|
-2.63%
|
✗
|
$86.9K |
| Apr 15, 2025 |
Apr 17, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
37.5
|
-15,329
|
-4.28%
|
✓
|
$91.2K |
| Dec 12, 2024 |
Feb 19, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
83.8
|
+13,700
|
3.97%
|
✗
|
$11.1K |
| Feb 17, 2025 |
Feb 19, 2025 |
PALEKAR ROHAN
|
CEO |
Sell |
51.3
|
-3,249
|
-0.38%
|
✗
|
$34.3K |
| Feb 17, 2025 |
Feb 19, 2025 |
Martins Ryan
|
CFO |
Sell |
52.5
|
-780
|
-0.29%
|
✗
|
$8.2K |
| Feb 17, 2025 |
Feb 19, 2025 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
51.3
|
-1,050
|
-0.33%
|
✗
|
$11.1K |
| Feb 9, 2025 |
Feb 11, 2025 |
PALEKAR ROHAN
|
CEO |
Sell |
42.5
|
-8,946
|
-1.02%
|
✗
|
$102.1K |
| Feb 9, 2025 |
Feb 11, 2025 |
Martins Ryan
|
CFO |
Sell |
46.3
|
-3,828
|
-1.40%
|
✗
|
$43.7K |
| Feb 9, 2025 |
Feb 11, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
46.3
|
-3,793
|
-1.09%
|
✗
|
$43.3K |
| Feb 9, 2025 |
Feb 11, 2025 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
46.3
|
-3,817
|
-1.18%
|
✗
|
$43.6K |
| Feb 3, 2025 |
Feb 5, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
DiRocco Derek
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
Zoth Lota S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
Altschuler Steven
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
LAPORTE KATHLEEN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
Hayden Michael R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
McWherter Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 5, 2025 |
Atkinson Edward Morrow III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2025 |
Feb 4, 2025 |
Martins Ryan
|
CFO |
Sell |
91.3
|
+76,662
|
38.79%
|
✗
|
$32K |
| Feb 1, 2025 |
Feb 4, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
91.3
|
+76,662
|
28.20%
|
✗
|
$32K |
| Feb 1, 2025 |
Feb 4, 2025 |
PALEKAR ROHAN
|
CEO |
Sell |
95.0
|
+402,402
|
85.39%
|
✗
|
$92.1K |
| Feb 1, 2025 |
Feb 4, 2025 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
91.3
|
+76,662
|
31.03%
|
✗
|
$32K |
| Feb 1, 2025 |
Feb 4, 2025 |
Sarena Francis Willard
|
COO |
Neutral |
90.0
|
+53,750
|
215.00%
|
✗
|
- |
| Jan 30, 2025 |
Feb 3, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+5,714,285
|
41.29%
|
✗
|
$50M |
| Jan 21, 2025 |
Jan 23, 2025 |
McWherter Charles
|
Director |
Buy |
95.0
|
+15,000
|
150.00%
|
✗
|
$99.9K |
| Jan 15, 2025 |
Jan 17, 2025 |
Le-Nguyen Quoc
|
Officer |
Sell |
37.5
|
-10,963
|
-3.88%
|
✓
|
$71.1K |
| Dec 12, 2024 |
Dec 16, 2024 |
Mansbach Harry H
|
Chief Medical Officer |
Neutral |
27.5
|
-95,000
|
-27.77%
|
✗
|
- |
| Dec 12, 2024 |
Dec 16, 2024 |
Le-Nguyen Quoc
|
Officer |
Neutral |
27.5
|
-95,000
|
-25.15%
|
✗
|
- |
| Dec 12, 2024 |
Dec 16, 2024 |
Martins Ryan
|
CFO |
Neutral |
27.5
|
-95,000
|
-32.47%
|
✗
|
- |
| Dec 6, 2024 |
Dec 10, 2024 |
PALEKAR ROHAN
|
CEO |
Buy |
78.8
|
+5,000
|
1.07%
|
✗
|
$39.5K |
| Dec 5, 2024 |
Dec 9, 2024 |
McWherter Charles
|
Director |
Buy |
95.0
|
+10,000
|
100.00%
|
✗
|
$80K |
| Nov 22, 2024 |
Nov 25, 2024 |
PALEKAR ROHAN
|
CEO |
Buy |
82.5
|
+10,000
|
2.19%
|
✗
|
$83.5K |
| Nov 14, 2024 |
Nov 18, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2024 |
Nov 1, 2024 |
Le-Nguyen Quoc
|
Officer |
Sell |
25.0
|
-27,955
|
-12.96%
|
✓
|
$227K |
| Sep 9, 2024 |
Sep 10, 2024 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
46.3
|
-5,352
|
-3.40%
|
✗
|
$45.3K |
| Sep 9, 2024 |
Sep 10, 2024 |
Martins Ryan
|
CFO |
Sell |
46.3
|
-3,212
|
-3.03%
|
✗
|
$27.2K |
| Sep 9, 2024 |
Sep 10, 2024 |
Le-Nguyen Quoc
|
Officer |
Sell |
46.3
|
-5,352
|
-2.42%
|
✗
|
$45.3K |
| Aug 17, 2024 |
Aug 19, 2024 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
50.0
|
-1,046
|
-0.66%
|
✗
|
$8.4K |
| Aug 17, 2024 |
Aug 19, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
48.8
|
-4,601
|
-1.00%
|
✗
|
$37K |
| Aug 17, 2024 |
Aug 19, 2024 |
Martins Ryan
|
CFO |
Sell |
50.0
|
-777
|
-0.73%
|
✗
|
$6.2K |
| Aug 17, 2024 |
Aug 19, 2024 |
Le-Nguyen Quoc
|
Officer |
Sell |
52.5
|
-1,046
|
-0.47%
|
✗
|
$8.4K |
| Aug 5, 2024 |
Aug 7, 2024 |
McWherter Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 5, 2024 |
Aug 7, 2024 |
Sarena Francis Willard
|
COO |
Neutral |
90.0
|
+25,000
|
100.00%
|
✗
|
- |
|
Aug 7, 2024 |
Sarena Francis Willard
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 7, 2024 |
McWherter Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 2, 2024 |
May 3, 2024 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 23, 2024 |
Babler Martin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 11, 2024 |
Apr 15, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2024 |
Apr 3, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
22.5
|
-52,718
|
-10.30%
|
✓
|
$575.2K |
| Mar 4, 2024 |
Mar 6, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+1,350,000
|
12.18%
|
✗
|
$20.7M |
| Feb 26, 2024 |
Feb 28, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
51.3
|
-4,477
|
-0.91%
|
✓
|
$48.2K |
| Feb 17, 2024 |
Feb 23, 2024 |
Martins Ryan
|
CFO |
Sell |
50.0
|
-778
|
-0.72%
|
✗
|
$7.6K |
| Feb 17, 2024 |
Feb 23, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
48.8
|
-4,602
|
-0.93%
|
✗
|
$44.8K |
| Feb 17, 2024 |
Feb 23, 2024 |
Le-Nguyen Quoc
|
Officer |
Sell |
51.3
|
-1,046
|
-0.47%
|
✗
|
$10.2K |
| Feb 17, 2024 |
Feb 23, 2024 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
48.8
|
-1,046
|
-0.66%
|
✗
|
$10.2K |
| Feb 9, 2024 |
Feb 13, 2024 |
Martins Ryan
|
CFO |
Sell |
46.3
|
-3,568
|
-3.22%
|
✗
|
$30.1K |
| Feb 9, 2024 |
Feb 13, 2024 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
46.3
|
-3,568
|
-2.19%
|
✗
|
$30.1K |
| Feb 9, 2024 |
Feb 13, 2024 |
Le-Nguyen Quoc
|
Officer |
Sell |
46.3
|
-3,568
|
-1.57%
|
✗
|
$30.1K |
| Feb 9, 2024 |
Feb 13, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
42.5
|
-12,670
|
-2.57%
|
✗
|
$107.1K |
| Feb 1, 2024 |
Feb 5, 2024 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
91.3
|
+47,560
|
41.18%
|
✗
|
$11.7K |
| Feb 1, 2024 |
Feb 5, 2024 |
Le-Nguyen Quoc
|
Officer |
Sell |
91.3
|
+47,560
|
26.54%
|
✗
|
$11.7K |
| Feb 1, 2024 |
Feb 5, 2024 |
Hayden Michael R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
DiRocco Derek
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
91.3
|
+144,932
|
41.56%
|
✗
|
$49.7K |
| Feb 1, 2024 |
Feb 5, 2024 |
Atkinson Edward Morrow III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
LAPORTE KATHLEEN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Altschuler Steven
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Zoth Lota S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Martins Ryan
|
CFO |
Sell |
90.0
|
+47,858
|
75.85%
|
✗
|
$8.7K |
| Jan 5, 2024 |
Jan 8, 2024 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
95.0
|
+15,329
|
15.30%
|
✗
|
$111.5K |
| Jan 5, 2024 |
Jan 8, 2024 |
Martins Ryan
|
CFO |
Sell |
95.0
|
+8,876
|
16.37%
|
✗
|
$70.6K |
| Jan 5, 2024 |
Jan 8, 2024 |
Le-Nguyen Quoc
|
Officer |
Sell |
90.0
|
+15,329
|
9.35%
|
✗
|
$111.5K |
| Jan 5, 2024 |
Jan 8, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
97.5
|
+47,489
|
15.77%
|
✗
|
$317.2K |
| Dec 29, 2023 |
Jan 3, 2024 |
PALEKAR ROHAN
|
CEO |
Sell |
22.5
|
-50,000
|
-14.24%
|
✓
|
$560K |
| Dec 11, 2023 |
Dec 13, 2023 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 9, 2023 |
Sep 12, 2023 |
Mansbach Harry H
|
Chief Medical Officer |
Sell |
42.5
|
-3,821
|
-3.67%
|
✗
|
$63.5K |